HEI3090 is an activator of the P2X7R receptor. This compound enhances the production of IL-18 by stimulating dendritic cells that express P2X7R, which in turn promotes the production of IFN-γ by natural killer cells and CD4T cells within tumors, triggering a sustained anti-tumor response. Additionally, HEI3090 can be used to improve the efficacy of αPD-1 therapy in non-small cell lung cancer (NSCLC).
Marketplace OffersShowing from 1 suppliers
Supplier
TargetMolSC
Pack Size
Estimated Lead Time
10-14 weeks
Purity
-
Inquiry
1
You cannot determine which compound library is the best fit for your project? Do you need a custom solution? AnyMol is always ready to help you.